Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68
Research Area 002: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68
Supports the development of inactivated Enterovirus D68 vaccines, preferably using adjuvants that minimize regulatory concerns and expedite vaccine development into a Phase I clinical trial.
Due Date: February 28, 2020, by 3 p.m. Eastern Time
Learn more about this opportunity in Funding News.
Global Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.